Antitachycardia devices: Realities and promises

Lawrence S. Klein, William M. Miles, Douglas P. Zipes

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Nonpharmacologic therapy for ventricular arrhythmias has gained growing attention with the development of the implantable cardioverter-defibrillator. In addition, the reports of adverse effects of drug therapy from several studies, including the Cardiac Arrhythmia Suppression Trial (CAST), have supported the need for these devices. The development of new implantable cardioverter-defibrillators that have the capability cf antitachycardia pacing, bradycardia pacing, cardioversion and defibrillation has enhanced their clinical utility. The currently available implantable cardioverter-defibrillators have been shown to significantly improve survival after sudden cardiac arrest in patients with life-threatening ventricular arrhythmias. Newer devices with expanded capabilities may reduce mortality even further. In this report the features of currently available antitachycardia devices and implantable cardioverter-defibrillators are reviewed and the features and current implant data on newer antitachycardia devices are discussed.

Original languageEnglish
Pages (from-to)1349-1362
Number of pages14
JournalJournal of the American College of Cardiology
Volume18
Issue number5
DOIs
StatePublished - Nov 1 1991

Fingerprint

Implantable Defibrillators
Cardiac Arrhythmias
Equipment and Supplies
Electric Countershock
Sudden Cardiac Death
Bradycardia
Drug Therapy
Survival
Mortality
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Antitachycardia devices : Realities and promises. / Klein, Lawrence S.; Miles, William M.; Zipes, Douglas P.

In: Journal of the American College of Cardiology, Vol. 18, No. 5, 01.11.1991, p. 1349-1362.

Research output: Contribution to journalArticle

Klein, Lawrence S. ; Miles, William M. ; Zipes, Douglas P. / Antitachycardia devices : Realities and promises. In: Journal of the American College of Cardiology. 1991 ; Vol. 18, No. 5. pp. 1349-1362.
@article{27b7a2e38e2942ee8df7f382e301de03,
title = "Antitachycardia devices: Realities and promises",
abstract = "Nonpharmacologic therapy for ventricular arrhythmias has gained growing attention with the development of the implantable cardioverter-defibrillator. In addition, the reports of adverse effects of drug therapy from several studies, including the Cardiac Arrhythmia Suppression Trial (CAST), have supported the need for these devices. The development of new implantable cardioverter-defibrillators that have the capability cf antitachycardia pacing, bradycardia pacing, cardioversion and defibrillation has enhanced their clinical utility. The currently available implantable cardioverter-defibrillators have been shown to significantly improve survival after sudden cardiac arrest in patients with life-threatening ventricular arrhythmias. Newer devices with expanded capabilities may reduce mortality even further. In this report the features of currently available antitachycardia devices and implantable cardioverter-defibrillators are reviewed and the features and current implant data on newer antitachycardia devices are discussed.",
author = "Klein, {Lawrence S.} and Miles, {William M.} and Zipes, {Douglas P.}",
year = "1991",
month = "11",
day = "1",
doi = "10.1016/0735-1097(91)90559-R",
language = "English",
volume = "18",
pages = "1349--1362",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Antitachycardia devices

T2 - Realities and promises

AU - Klein, Lawrence S.

AU - Miles, William M.

AU - Zipes, Douglas P.

PY - 1991/11/1

Y1 - 1991/11/1

N2 - Nonpharmacologic therapy for ventricular arrhythmias has gained growing attention with the development of the implantable cardioverter-defibrillator. In addition, the reports of adverse effects of drug therapy from several studies, including the Cardiac Arrhythmia Suppression Trial (CAST), have supported the need for these devices. The development of new implantable cardioverter-defibrillators that have the capability cf antitachycardia pacing, bradycardia pacing, cardioversion and defibrillation has enhanced their clinical utility. The currently available implantable cardioverter-defibrillators have been shown to significantly improve survival after sudden cardiac arrest in patients with life-threatening ventricular arrhythmias. Newer devices with expanded capabilities may reduce mortality even further. In this report the features of currently available antitachycardia devices and implantable cardioverter-defibrillators are reviewed and the features and current implant data on newer antitachycardia devices are discussed.

AB - Nonpharmacologic therapy for ventricular arrhythmias has gained growing attention with the development of the implantable cardioverter-defibrillator. In addition, the reports of adverse effects of drug therapy from several studies, including the Cardiac Arrhythmia Suppression Trial (CAST), have supported the need for these devices. The development of new implantable cardioverter-defibrillators that have the capability cf antitachycardia pacing, bradycardia pacing, cardioversion and defibrillation has enhanced their clinical utility. The currently available implantable cardioverter-defibrillators have been shown to significantly improve survival after sudden cardiac arrest in patients with life-threatening ventricular arrhythmias. Newer devices with expanded capabilities may reduce mortality even further. In this report the features of currently available antitachycardia devices and implantable cardioverter-defibrillators are reviewed and the features and current implant data on newer antitachycardia devices are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0025943097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025943097&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(91)90559-R

DO - 10.1016/0735-1097(91)90559-R

M3 - Article

C2 - 1918713

AN - SCOPUS:0025943097

VL - 18

SP - 1349

EP - 1362

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 5

ER -